Table 1.
Characteristic | Patients (n = 46) |
Sex (M/F) | 30/16 |
Age (yr) | 57.9 ± 1.28 |
Time from OLT (mo) | 26.3 ± 5.1 |
ALT (IU/L) | 152.3 ± 17.8 |
AST (IU/L) | 105.9 ± 11.5 |
Gamma-GT (IU/L) | 188.7 ± 39.3 |
Alkaline phosphatases (IU/L) | 364.7 ± 39.9 |
Bilirubin (mg/L) | 1.7 ± 0.37 |
Viral load (log10) | 6.25 ± 0.09 |
Genotypes 1/4 vs 2/3 | 36/10 |
F1/F2/F3/F4 | 13/16/9/8 |
Fibrosing cholestatic hepatitis | 3 |
Cyclosporine A vs tacrolimus | 7/39 |
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; Gamma-GT: Gamma-glutamyl transpeptidase; M/F: Male/female.